Amlo Biosciences
About:
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Website: http://www.amlo-biosciences.com
Top Investors: Northstar Ventures, Future Planet Capital, Esperante Ventures, Ascension Life Fund
Description:
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Total Funding Amount:
2.45M GBP
Headquarters Location:
Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom
Founded Date:
2017-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-04-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai